Ofatumumab
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Afutuzumab Market Research Report 2024
1 Afutuzumab Market Overview
1.1 Product Overview and Scope of Afutuzumab
1.2 Afutuzumab Segment by Type
1.2.1 Global Afutuzumab Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Patent
1.2.3 Generic
1.3 Afutuzumab Segment by Application
1.3.1 Global Afutuzumab Sales Comparison by Application: (2022-2028)
1.3.2 Chronic Lymphocytic Leukemia
1.3.3 Follicular Lymphoma
1.4 Global Afutuzumab Market Size Estimates and Forecasts
1.4.1 Global Afutuzumab Revenue 2017-2028
1.4.2 Global Afutuzumab Sales 2017-2028
1.4.3 Afutuzumab Market Size by Region: 2017 Versus 2021 Versus 2028
2 Afutuzumab Market Competition by Manufacturers
2.1 Global Afutuzumab Sales Market Share by Manufacturers (2017-2022)
2.2 Global Afutuzumab Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Afutuzumab Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Afutuzumab Manufacturing Sites, Area Served, Product Type
2.5 Afutuzumab Market Competitive Situation and Trends
2.5.1 Afutuzumab Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Afutuzumab Players Market Share by Revenue
2.5.3 Global Afutuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Afutuzumab Retrospective Market Scenario by Region
3.1 Global Afutuzumab Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Afutuzumab Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Afutuzumab Market Facts & Figures by Country
3.3.1 North America Afutuzumab Sales by Country
3.3.2 North America Afutuzumab Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Afutuzumab Market Facts & Figures by Country
3.4.1 Europe Afutuzumab Sales by Country
3.4.2 Europe Afutuzumab Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Afutuzumab Market Facts & Figures by Region
3.5.1 Asia Pacific Afutuzumab Sales by Region
3.5.2 Asia Pacific Afutuzumab Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Afutuzumab Market Facts & Figures by Country
3.6.1 Latin America Afutuzumab Sales by Country
3.6.2 Latin America Afutuzumab Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Afutuzumab Market Facts & Figures by Country
3.7.1 Middle East and Africa Afutuzumab Sales by Country
3.7.2 Middle East and Africa Afutuzumab Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Afutuzumab Historic Market Analysis by Type
4.1 Global Afutuzumab Sales Market Share by Type (2017-2022)
4.2 Global Afutuzumab Revenue Market Share by Type (2017-2022)
4.3 Global Afutuzumab Price by Type (2017-2022)
5 Global Afutuzumab Historic Market Analysis by Application
5.1 Global Afutuzumab Sales Market Share by Application (2017-2022)
5.2 Global Afutuzumab Revenue Market Share by Application (2017-2022)
5.3 Global Afutuzumab Price by Application (2017-2022)
6 Key Companies Profiled
6.1 BOC Sciences
6.1.1 BOC Sciences Corporation Information
6.1.2 BOC Sciences Description and Business Overview
6.1.3 BOC Sciences Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.1.4 BOC Sciences Afutuzumab Product Portfolio
6.1.5 BOC Sciences Recent Developments/Updates
6.2 Carbosynth
6.2.1 Carbosynth Corporation Information
6.2.2 Carbosynth Description and Business Overview
6.2.3 Carbosynth Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Carbosynth Afutuzumab Product Portfolio
6.2.5 Carbosynth Recent Developments/Updates
6.3 Roche Group
6.3.1 Roche Group Corporation Information
6.3.2 Roche Group Description and Business Overview
6.3.3 Roche Group Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Roche Group Afutuzumab Product Portfolio
6.3.5 Roche Group Recent Developments/Updates
6.4 TargetMol Chemicals
6.4.1 TargetMol Chemicals Corporation Information
6.4.2 TargetMol Chemicals Description and Business Overview
6.4.3 TargetMol Chemicals Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 TargetMol Chemicals Afutuzumab Product Portfolio
6.4.5 TargetMol Chemicals Recent Developments/Updates
6.5 Wonda Science
6.5.1 Wonda Science Corporation Information
6.5.2 Wonda Science Description and Business Overview
6.5.3 Wonda Science Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Wonda Science Afutuzumab Product Portfolio
6.5.5 Wonda Science Recent Developments/Updates
6.6 Absin Bioscience
6.6.1 Absin Bioscience Corporation Information
6.6.2 Absin Bioscience Description and Business Overview
6.6.3 Absin Bioscience Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Absin Bioscience Afutuzumab Product Portfolio
6.6.5 Absin Bioscience Recent Developments/Updates
6.7 Chunchuang (Wuhan) Technology
6.6.1 Chunchuang (Wuhan) Technology Corporation Information
6.6.2 Chunchuang (Wuhan) Technology Description and Business Overview
6.6.3 Chunchuang (Wuhan) Technology Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Chunchuang (Wuhan) Technology Afutuzumab Product Portfolio
6.7.5 Chunchuang (Wuhan) Technology Recent Developments/Updates
6.8 Hubei Kele Fine Chemical
6.8.1 Hubei Kele Fine Chemical Corporation Information
6.8.2 Hubei Kele Fine Chemical Description and Business Overview
6.8.3 Hubei Kele Fine Chemical Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hubei Kele Fine Chemical Afutuzumab Product Portfolio
6.8.5 Hubei Kele Fine Chemical Recent Developments/Updates
6.9 Jiangxi Ruiweier Biotechnology
6.9.1 Jiangxi Ruiweier Biotechnology Corporation Information
6.9.2 Jiangxi Ruiweier Biotechnology Description and Business Overview
6.9.3 Jiangxi Ruiweier Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Jiangxi Ruiweier Biotechnology Afutuzumab Product Portfolio
6.9.5 Jiangxi Ruiweier Biotechnology Recent Developments/Updates
6.10 Qingdao Jieshikang Biotechnology
6.10.1 Qingdao Jieshikang Biotechnology Corporation Information
6.10.2 Qingdao Jieshikang Biotechnology Description and Business Overview
6.10.3 Qingdao Jieshikang Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Qingdao Jieshikang Biotechnology Afutuzumab Product Portfolio
6.10.5 Qingdao Jieshikang Biotechnology Recent Developments/Updates
6.11 Shanghai Biochempartner
6.11.1 Shanghai Biochempartner Corporation Information
6.11.2 Shanghai Biochempartner Afutuzumab Description and Business Overview
6.11.3 Shanghai Biochempartner Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Shanghai Biochempartner Afutuzumab Product Portfolio
6.11.5 Shanghai Biochempartner Recent Developments/Updates
6.12 Shanghai Macklin Biochemical
6.12.1 Shanghai Macklin Biochemical Corporation Information
6.12.2 Shanghai Macklin Biochemical Afutuzumab Description and Business Overview
6.12.3 Shanghai Macklin Biochemical Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Shanghai Macklin Biochemical Afutuzumab Product Portfolio
6.12.5 Shanghai Macklin Biochemical Recent Developments/Updates
6.13 Shanghai Qiming Biotechnology
6.13.1 Shanghai Qiming Biotechnology Corporation Information
6.13.2 Shanghai Qiming Biotechnology Afutuzumab Description and Business Overview
6.13.3 Shanghai Qiming Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Shanghai Qiming Biotechnology Afutuzumab Product Portfolio
6.13.5 Shanghai Qiming Biotechnology Recent Developments/Updates
6.14 Shanghai Saimai Biotechnology
6.14.1 Shanghai Saimai Biotechnology Corporation Information
6.14.2 Shanghai Saimai Biotechnology Afutuzumab Description and Business Overview
6.14.3 Shanghai Saimai Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Shanghai Saimai Biotechnology Afutuzumab Product Portfolio
6.14.5 Shanghai Saimai Biotechnology Recent Developments/Updates
6.15 Shanghai Shize Biological Technology
6.15.1 Shanghai Shize Biological Technology Corporation Information
6.15.2 Shanghai Shize Biological Technology Afutuzumab Description and Business Overview
6.15.3 Shanghai Shize Biological Technology Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Shanghai Shize Biological Technology Afutuzumab Product Portfolio
6.15.5 Shanghai Shize Biological Technology Recent Developments/Updates
6.16 Shanghai Yifei Biotechnology
6.16.1 Shanghai Yifei Biotechnology Corporation Information
6.16.2 Shanghai Yifei Biotechnology Afutuzumab Description and Business Overview
6.16.3 Shanghai Yifei Biotechnology Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Shanghai Yifei Biotechnology Afutuzumab Product Portfolio
6.16.5 Shanghai Yifei Biotechnology Recent Developments/Updates
6.17 Shanghai Yu'ang Chemical
6.17.1 Shanghai Yu'ang Chemical Corporation Information
6.17.2 Shanghai Yu'ang Chemical Afutuzumab Description and Business Overview
6.17.3 Shanghai Yu'ang Chemical Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Shanghai Yu'ang Chemical Afutuzumab Product Portfolio
6.17.5 Shanghai Yu'ang Chemical Recent Developments/Updates
6.18 Tianmen Hengchang Chemical
6.18.1 Tianmen Hengchang Chemical Corporation Information
6.18.2 Tianmen Hengchang Chemical Afutuzumab Description and Business Overview
6.18.3 Tianmen Hengchang Chemical Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Tianmen Hengchang Chemical Afutuzumab Product Portfolio
6.18.5 Tianmen Hengchang Chemical Recent Developments/Updates
6.19 Wuhan Sunrise Technology Development
6.19.1 Wuhan Sunrise Technology Development Corporation Information
6.19.2 Wuhan Sunrise Technology Development Afutuzumab Description and Business Overview
6.19.3 Wuhan Sunrise Technology Development Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Wuhan Sunrise Technology Development Afutuzumab Product Portfolio
6.19.5 Wuhan Sunrise Technology Development Recent Developments/Updates
6.20 Wuhan Yingnuo Pharmaceutical Technology
6.20.1 Wuhan Yingnuo Pharmaceutical Technology Corporation Information
6.20.2 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Description and Business Overview
6.20.3 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product Portfolio
6.20.5 Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
7 Afutuzumab Manufacturing Cost Analysis
7.1 Afutuzumab Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Afutuzumab
7.4 Afutuzumab Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Afutuzumab Distributors List
8.3 Afutuzumab Customers
9 Afutuzumab Market Dynamics
9.1 Afutuzumab Industry Trends
9.2 Afutuzumab Market Drivers
9.3 Afutuzumab Market Challenges
9.4 Afutuzumab Market Restraints
10 Global Market Forecast
10.1 Afutuzumab Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Afutuzumab by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Afutuzumab by Type (2023-2028)
10.2 Afutuzumab Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Afutuzumab by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Afutuzumab by Application (2023-2028)
10.3 Afutuzumab Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Afutuzumab by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Afutuzumab by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Afutuzumab Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
Table 2. Global Afutuzumab Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
Table 3. Global Afutuzumab Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Afutuzumab Market Competitive Situation by Manufacturers in 2021
Table 5. Global Afutuzumab Sales (Kg) of Key Manufacturers (2017-2022)
Table 6. Global Afutuzumab Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Afutuzumab Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Afutuzumab Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Afutuzumab Average Price (US$/Kg) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Afutuzumab Manufacturing Sites and Area Served
Table 11. Manufacturers Afutuzumab Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Afutuzumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Afutuzumab as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Afutuzumab Sales by Region (2017-2022) & (Kg)
Table 16. Global Afutuzumab Sales Market Share by Region (2017-2022)
Table 17. Global Afutuzumab Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Afutuzumab Revenue Market Share by Region (2017-2022)
Table 19. North America Afutuzumab Sales by Country (2017-2022) & (Kg)
Table 20. North America Afutuzumab Sales Market Share by Country (2017-2022)
Table 21. North America Afutuzumab Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Afutuzumab Revenue Market Share by Country (2017-2022)
Table 23. Europe Afutuzumab Sales by Country (2017-2022) & (Kg)
Table 24. Europe Afutuzumab Sales Market Share by Country (2017-2022)
Table 25. Europe Afutuzumab Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Afutuzumab Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Afutuzumab Sales by Region (2017-2022) & (Kg)
Table 28. Asia Pacific Afutuzumab Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Afutuzumab Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Afutuzumab Revenue Market Share by Region (2017-2022)
Table 31. Latin America Afutuzumab Sales by Country (2017-2022) & (Kg)
Table 32. Latin America Afutuzumab Sales Market Share by Country (2017-2022)
Table 33. Latin America Afutuzumab Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Afutuzumab Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Afutuzumab Sales by Country (2017-2022) & (Kg)
Table 36. Middle East and Africa Afutuzumab Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Afutuzumab Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Afutuzumab Revenue Market Share by Country (2017-2022)
Table 39. Global Afutuzumab Sales by Type (2017-2022) & (Kg)
Table 40. Global Afutuzumab Sales Market Share by Type (2017-2022)
Table 41. Global Afutuzumab Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Afutuzumab Revenue Share by Type (2017-2022)
Table 43. Global Afutuzumab Price by Type (2017-2022) & (US$/Kg)
Table 44. Global Afutuzumab Sales (Kg) by Application (2017-2022)
Table 45. Global Afutuzumab Sales Market Share by Application (2017-2022)
Table 46. Global Afutuzumab Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Afutuzumab Revenue Share by Application (2017-2022)
Table 48. Global Afutuzumab Price by Application (2017-2022) & (US$/Kg)
Table 49. BOC Sciences Corporation Information
Table 50. BOC Sciences Description and Business Overview
Table 51. BOC Sciences Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 52. BOC Sciences Afutuzumab Product
Table 53. BOC Sciences Recent Developments/Updates
Table 54. Carbosynth Corporation Information
Table 55. Carbosynth Description and Business Overview
Table 56. Carbosynth Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 57. Carbosynth Afutuzumab Product
Table 58. Carbosynth Recent Developments/Updates
Table 59. Roche Group Corporation Information
Table 60. Roche Group Description and Business Overview
Table 61. Roche Group Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 62. Roche Group Afutuzumab Product
Table 63. Roche Group Recent Developments/Updates
Table 64. TargetMol Chemicals Corporation Information
Table 65. TargetMol Chemicals Description and Business Overview
Table 66. TargetMol Chemicals Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 67. TargetMol Chemicals Afutuzumab Product
Table 68. TargetMol Chemicals Recent Developments/Updates
Table 69. Wonda Science Corporation Information
Table 70. Wonda Science Description and Business Overview
Table 71. Wonda Science Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 72. Wonda Science Afutuzumab Product
Table 73. Wonda Science Recent Developments/Updates
Table 74. Absin Bioscience Corporation Information
Table 75. Absin Bioscience Description and Business Overview
Table 76. Absin Bioscience Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 77. Absin Bioscience Afutuzumab Product
Table 78. Absin Bioscience Recent Developments/Updates
Table 79. Chunchuang (Wuhan) Technology Corporation Information
Table 80. Chunchuang (Wuhan) Technology Description and Business Overview
Table 81. Chunchuang (Wuhan) Technology Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 82. Chunchuang (Wuhan) Technology Afutuzumab Product
Table 83. Chunchuang (Wuhan) Technology Recent Developments/Updates
Table 84. Hubei Kele Fine Chemical Corporation Information
Table 85. Hubei Kele Fine Chemical Description and Business Overview
Table 86. Hubei Kele Fine Chemical Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 87. Hubei Kele Fine Chemical Afutuzumab Product
Table 88. Hubei Kele Fine Chemical Recent Developments/Updates
Table 89. Jiangxi Ruiweier Biotechnology Corporation Information
Table 90. Jiangxi Ruiweier Biotechnology Description and Business Overview
Table 91. Jiangxi Ruiweier Biotechnology Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 92. Jiangxi Ruiweier Biotechnology Afutuzumab Product
Table 93. Jiangxi Ruiweier Biotechnology Recent Developments/Updates
Table 94. Qingdao Jieshikang Biotechnology Corporation Information
Table 95. Qingdao Jieshikang Biotechnology Description and Business Overview
Table 96. Qingdao Jieshikang Biotechnology Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 97. Qingdao Jieshikang Biotechnology Afutuzumab Product
Table 98. Qingdao Jieshikang Biotechnology Recent Developments/Updates
Table 99. Shanghai Biochempartner Corporation Information
Table 100. Shanghai Biochempartner Description and Business Overview
Table 101. Shanghai Biochempartner Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 102. Shanghai Biochempartner Afutuzumab Product
Table 103. Shanghai Biochempartner Recent Developments/Updates
Table 104. Shanghai Macklin Biochemical Corporation Information
Table 105. Shanghai Macklin Biochemical Description and Business Overview
Table 106. Shanghai Macklin Biochemical Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 107. Shanghai Macklin Biochemical Afutuzumab Product
Table 108. Shanghai Macklin Biochemical Recent Developments/Updates
Table 109. Shanghai Qiming Biotechnology Corporation Information
Table 110. Shanghai Qiming Biotechnology Description and Business Overview
Table 111. Shanghai Qiming Biotechnology Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 112. Shanghai Qiming Biotechnology Afutuzumab Product
Table 113. Shanghai Qiming Biotechnology Recent Developments/Updates
Table 114. Shanghai Saimai Biotechnology Corporation Information
Table 115. Shanghai Saimai Biotechnology Description and Business Overview
Table 116. Shanghai Saimai Biotechnology Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 117. Shanghai Saimai Biotechnology Afutuzumab Product
Table 118. Shanghai Saimai Biotechnology Recent Developments/Updates
Table 119. Shanghai Shize Biological Technology Corporation Information
Table 120. Shanghai Shize Biological Technology Description and Business Overview
Table 121. Shanghai Shize Biological Technology Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 122. Shanghai Shize Biological Technology Afutuzumab Product
Table 123. Shanghai Shize Biological Technology Recent Developments/Updates
Table 124. Shanghai Yifei Biotechnology Corporation Information
Table 125. Shanghai Yifei Biotechnology Description and Business Overview
Table 126. Shanghai Yifei Biotechnology Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 127. Shanghai Yifei Biotechnology Afutuzumab Product
Table 128. Shanghai Yifei Biotechnology Recent Developments/Updates
Table 129. Shanghai Yu'ang Chemical Corporation Information
Table 130. Shanghai Yu'ang Chemical Description and Business Overview
Table 131. Shanghai Yu'ang Chemical Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 132. Shanghai Yu'ang Chemical Afutuzumab Product
Table 133. Shanghai Yu'ang Chemical Recent Developments/Updates
Table 134. Tianmen Hengchang Chemical Corporation Information
Table 135. Tianmen Hengchang Chemical Description and Business Overview
Table 136. Tianmen Hengchang Chemical Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 137. Tianmen Hengchang Chemical Afutuzumab Product
Table 138. Tianmen Hengchang Chemical Recent Developments/Updates
Table 139. Wuhan Sunrise Technology Development Corporation Information
Table 140. Wuhan Sunrise Technology Development Description and Business Overview
Table 141. Wuhan Sunrise Technology Development Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 142. Wuhan Sunrise Technology Development Afutuzumab Product
Table 143. Wuhan Sunrise Technology Development Recent Developments/Updates
Table 144. Wuhan Yingnuo Pharmaceutical Technology Corporation Information
Table 145. Wuhan Yingnuo Pharmaceutical Technology Description and Business Overview
Table 146. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 147. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product
Table 148. Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Afutuzumab Distributors List
Table 152. Afutuzumab Customers List
Table 153. Afutuzumab Market Trends
Table 154. Afutuzumab Market Drivers
Table 155. Afutuzumab Market Challenges
Table 156. Afutuzumab Market Restraints
Table 157. Global Afutuzumab Sales Forecast by Type (2023-2028) & (Kg)
Table 158. Global Afutuzumab Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Afutuzumab Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Afutuzumab Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Afutuzumab Sales Forecast by Application (2023-2028) & (Kg)
Table 162. Global Afutuzumab Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Afutuzumab Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Afutuzumab Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Afutuzumab Sales Forecast by Region (2023-2028) & (Kg)
Table 166. Global Afutuzumab Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Afutuzumab Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Afutuzumab Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Afutuzumab
Figure 2. Global Afutuzumab Market Share by Type in 2021 & 2028
Figure 3. Patent Product Picture
Figure 4. Generic Product Picture
Figure 5. Global Afutuzumab Market Share by Application in 2021 & 2028
Figure 6. Chronic Lymphocytic Leukemia
Figure 7. Follicular Lymphoma
Figure 8. Global Afutuzumab Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Afutuzumab Market Size (2017-2028) & (US$ Million)
Figure 10. Global Afutuzumab Sales (2017-2028) & (Kg)
Figure 11. Afutuzumab Sales Share by Manufacturers in 2021
Figure 12. Global Afutuzumab Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Afutuzumab Players: Market Share by Revenue in 2021
Figure 14. Afutuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Afutuzumab Sales Market Share by Region (2017-2022)
Figure 16. Global Afutuzumab Sales Market Share by Region in 2021
Figure 17. Global Afutuzumab Revenue Market Share by Region (2017-2022)
Figure 18. Global Afutuzumab Revenue Market Share by Region in 2021
Figure 19. United States Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Turkey Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Saudi Arabia Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. UAE Afutuzumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Sales Market Share of Afutuzumab by Type (2017-2022)
Figure 42. Manufacturing Cost Structure of Afutuzumab
Figure 43. Manufacturing Process Analysis of Afutuzumab
Figure 44. Afutuzumab Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BOC Sciences Carbosynth Roche Group TargetMol Chemicals Wonda Science Absin Bioscience Chunchuang (Wuhan) Technology Hubei Kele Fine Chemical Jiangxi Ruiweier Biotechnology Qingdao Jieshikang Biotechnology Shanghai Biochempartner Shanghai Macklin Biochemical Shanghai Qiming Biotechnology Shanghai Saimai Biotechnology Shanghai Shize Biological Technology Shanghai Yifei Biotechnology Shanghai Yu'ang Chemical Tianmen Hengchang Chemical Wuhan Sunrise Technology Development Wuhan Yingnuo Pharmaceutical Technology